Cryptococcal meningitis in an HIV-1-infected person: Relapses or IRIS? Case report and review of the literature

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 11, 2013, Pages 1555-1559

  Nunnari, G ^a   Gussio, M ^a   Pinzone, M R ^a   Martellotta, F ^b   Cosentino, S ^a   Cacopardo, B ^a   Celesia, B M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Antiretroviral therapy; Cryptococcal meningitis; HIV

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CEFOTAXIME; DEXAMETHASONE; DICLOFENAC; EMTRICITABINE; FLUCONAZOLE; FUNGUS ANTIGEN; GLUCOSE; INDOMETACIN; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; VIRUS RNA;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARM; CASE REPORT; CAUDATE NUCLEUS; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCAL SPECIFIC IMMUNE RESPONSE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; KAPOSI SARCOMA; LEG; LEPTOMENINX; LUMBAR PUNCTURE; MAINTENANCE THERAPY; MALE; MEN WHO HAVE SEX WITH MEN; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PENIS; PRECENTRAL ROSTRAL PARAMEDIAN PARENCHYMA; RELAPSE; REVIEW; SUBCORTEX; VIRUS LOAD; VOMITING; ACQUIRED IMMUNE DEFICIENCY SYNDROME; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; RECURRENT DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MENINGITIS, CRYPTOCOCCAL; RECURRENCE;

EID: 84883485230     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. PALELLA FJ, BAKER RK, MOORMAN AC, CHMIEL JS, WOOD KC, BROOKS JT, HOLMBERG SD; HIV OUTPATIENT STUDY INVESTIGATORS. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34. (Pubitemid 44306484)
2. ZANET E, BERRETTA M, DI BENEDETTO F, TALAMINI R, BALLARIN R, NUNNARI G, BERRETTA S, RIDOLFO A, LLESHI A, ZANGHÌ A, CAPPELLANI A, TIRELLI U. Pancreatic cancer in HIV-positive patients: a clinical casecontrol study. Pancreas 2012; 41: 1331-1335.
3. BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A, GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A, IZZI I, TORRESIN A, DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011; 16: 1258-1269.
4. BERRETTA M, LLESHI A, CAPPELLANI A, BEARZ A, SPINA M, TALAMINI R, CACOPARDO B, NUNNARI G, MONTESARCHIO V, IZZI I, LANZAFAME M, NASTI G, BASILE F, BERRETTA S, FISICHELLA R, SCHIANTARELLI C, GARLASSI E, RIDOLFO A, GUELLA L, TIRELLI U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010; 8: 218-222.
5. BERRETTA M, CAPPELLANI A, DI BENEDETTO F, LLESHI A, TALAMINI R, CANZONIERI V, ZANET E, BEARZ A, NASTI G, LACCHIN T, BERRETTA S, FISICHELLA R, BALESTRERI L, TORRESIN A, IZZI I, ORTOLANI P, TIRELLI U. Clinical presentation and outcome of colorectal cancer in hivpositive patients: a clinical case-control study. Onkologie 2009; 32: 319-324.
6. BERRETTA M, ZANET E, BASILE F, RIDOLFO AL, DI BENEDETTO F, BEARZ A, BERRETTA S, NASTI G, TIRELLI U. HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population. Onkologie 2010; 33: 203-204.
7. ZANET E, BERRETTA M, MARTELLOTTA F, CACOPARDO B, FISICHELLA R, TAVIO M, BERRETTA S, TIRELLI U. Anal cancer: focus on HIV-positive patients in the HAART era. Curr HIV Res 2011; 9: 70-81.
8. NUNNARI G, XU Y, ACHEAMPONG EA, FANG J, DANIEL R, ZHANG C, ZHANG H, MUKHTAR M, POMERANTZ RJ. Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 2005; 11: 319-328. (Pubitemid 41614511)
9. NUNNARI G, POMERANTZ RJ. IL-7 as a potential therapy for HIV-1-infected individuals. Expert Opin Biol Ther 2005; 5: 1421-1426. (Pubitemid 41579427)
10. NUNNARI G, BERRETTA M, PINZONE MR, DI ROSA M, CAPPELLANI A, BERRETTA S, TIRELLI U, MALAGUARNERA M, SCHNELL JM, CACOPARDO B. Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci 2012; 16: 1257-1270.
11. MARTELLOTTA F, BERRETTA M, CACOPARDO B, FISICHELLA R, SCHIOPPA O, ZANGHÌ A, SPARTÀ D, CAPPELLANI A, TALAMINI R, IZZI I, RIDOLFO A, TORRESIN A, FIORICA F, TIRELLI U. Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience. Eur Rev Med Pharmacol Sci 2012; 16: 1283-1291.
12. BERRETTA M, DI BENEDETTO F, DAL MASO L, CACOPARDO B, NASTI G, FACCHINI G, BEARZ A, SPINA M, GARLASSI E, DE RE V, FIORICA F, LLESHI A, TIRELLI U. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs 2013; 24: 212-218.
13. MARTELLOTTA F, BERRETTA M, VACCHER E, SCHIOPPA O, ZANET E, TIRELLI U. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res 2009; 7: 634-638.
14. BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003; 22: 6646-6659. (Pubitemid 37372345)
15. PINZONE MR, DI ROSA M, CACOPARDO B, NUNNARI G. HIV RNA suppression and immune restoration: can we do better? Clin Dev Immunol 2012; 2012: 515962.
16. NUNNARI G, COCO C, PINZONE MR, PAVONE P, BERRETTA M, DI ROSA M, SCHNELL M, CALABRESE G, CACOPARDO B. The role of micronutrients in the diet of HIV- 1-infected individuals. Front Biosci (Elite Ed) 2012; 4: 2442-2456.
17. PINZONE MR, CACOPARDO B, CONDORELLI F, DI ROSA M, NUNNARI G. Sirtuin-1 and HIV-1: An Overview. Curr Drug Targets 2013; 14: 648-652.
18. PINZONE MR, FIORICA F, DI ROSA M, MALAGUARNERA G, MALAGUARNERA L, CACOPARDO B, ZANGHÌ G, NUNNARI G. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci 2012; 16: 1377-1388.
19. NUNNARI G, SMITH JA, DANIEL R. HIV-1 Tat and AIDSassociated cancer: targeting the cellular anti-cancer barrier. J Exp Clin Cancer Res 2008; 27: 3.
20. NUNNARI G, OTERO M, DORNADULA G, VANELLA M, ZHANG H, FRANK I, POMERANTZ RJ. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS 2002; 16: 39-45. (Pubitemid 34062180)
21. DORNADULA G, NUNNARI G, VANELLA M, ROMAN J, BABINCHAK T, DESIMONE J, STERN J, BRAFFMAN M, ZHANG H, POMERANTZ RJ. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups. J Infect Dis 2001; 183: 1682-1687. (Pubitemid 32466709)
22. OTERO M, NUNNARI G, LETO D, SULLIVAN J, WANG FX, FRANK I, XU Y, PATEL C, DORNADULA G, KULKOSKY J, POMERANTZ RJ. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART. AIDS Res Hum Retroviruses 2003; 19: 1097-1103. (Pubitemid 38037379)
23. NUNNARI G, ARGYRIS E, FANG J, MEHLMAN KE, POMERANTZ RJ, DANIEL R. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology 2005; 335: 177-184. (Pubitemid 40544907)
24. SMITH JA, NUNNARI G, PREUSS M, POMERANTZ RJ, DANIEL R. Pentoxifylline suppresses transduction by HIV-1- based vectors. Intervirology 2007; 50: 377-386. (Pubitemid 350014922)
25. PINZONE MR, DI ROSA M, MALAGUARNERA M, MADEDDU G, FOCÀ E, CECCARELLI G, D'ETTORRE G, VULLO V, FISICHELLA R, CACOPARDO B, NUNNARI G. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci 2013; 17: 1218-1232.
26. HIRSCH HH, KAUFMANN G, SENDI P, BATTEGAY M. Immune Reconstitution in HIV-Infected Patients. Clin Infect Dis 2004; 38: 1159-1166. (Pubitemid 38951265)
27. RATNAM I, CHIU C, KANDALA NB, EASTERBROOK PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42: 418-427. (Pubitemid 43122323)
28. BONHAM S, MEYA DB, BOHJANEN PR, BOULWARE DR. Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. Biomark Med 2008; 2: 349-361.
29. LORTHOLARY O, FONTANET A, MÉMAIN N, MARTIN A, SITBON K, DROMER F; FRENCH CRYPTOCOCCOSIS STUDY GROUP. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19: 1043-1049. (Pubitemid 40961144)
30. PUTIGNANI L, ANTONUCCI G, PAGLIA MG, VINCENZI L, FESTA A, DE MORI P, LOIACONO L, VISCA P. Cryptococcal lymphadenitis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a case report and review of the literature. Int J Immunopathol Pharmacol 2008; 21: 751-756.
31. SINGH N, PERFECT JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401. (Pubitemid 46765196)
32. SINGH N, LORTHOLARY O, ALEXANDER BD, GUPTA KL, JOHN GT, PURSELL K, MUNOZ P, KLINTMALM GB, STOSOR V, DEL BUSTO R, LIMAYE AP, SOMANI J, LYON M, HOUSTON S, HOUSE AA, PRUETT TL, ORLOFF S, HUMAR A, DOWDY L, GARCIA-DIAZ J, KALIL AC, FISHER RA, HUSAIN S; CRYPTOCOCCAL COLLABORATIVE TRANSPLANT STUDY GROUP. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005; 40: 1756-1761. (Pubitemid 40799944)
33. SINGH N, PERFECT JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 2007; 45: 1192-1199. (Pubitemid 47580319)
34. HADDOW LJ, COLEBUNDERS R, MEINTJES G, LAWN SD, ELLIOTT JH, MANABE YC, BOHJANEN PR, SUNGKANUPARPH S, EASTERBROOK PJ, FRENCH MA, BOULWARE DR, ON BEHALF OF THE INTERNATIONAL NETWORK FOR THE STUDY OF HIV ASSOCIATED IRIS (INSHI). Cryptococcal immune reconstitution inflammatory syndrome in hiv-1-infected individuals: literature review and proposed clinical case definitions. Lancet Infect Dis 2010; 10: 791-802.
35. SHELBURNE SA, DARCOURT J, WHITE WA, GREENBERG SB, HAMILL RJ, ATMAR RL, VISNEGARWALA F. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-1052. (Pubitemid 40418316)
36. BICANIC T, MEINTJES G, REBE K, WILLIAMS A, LOYSE A, WOOD R, HAYES M, JAFFAR S, HARRISON T. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009; 51: 130-134.
37. BOULWARE DR, BONHAM SC, MEYA DB, WIESNER DL, PARK GS, KAMBUGU A, JANOFF EN, BOHJANEN PR. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis 2010; 202: 962-970.
38. SUNGKANUPARPH S, FILLER SG, CHETCHOTISAKD P, PAPPAS PG, NOLEN TL, MANOSUTHI W, ANEKTHANANON T, MORRIS MI, SUPPARATPINYO K, KOPETSKIE H, KENDRICK AS, JOHNSON PC, SOBEL JD, LARSEN RA. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis 2009; 49: 931-934.
39. JARVIS JN, LAWN SD, VOGT M, BANGANI N, WOOD R, HARRISON TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009; 48: 856-862.
40. PONGSAI P, ATAMASIRIKUL K, SUNGKANUPARPH S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. J Infect 2010; 60: 474-477.
41. PERFECT JR, DISMUKES WE, DROMER F, GOLDMAN DL, GRAYBILL JR, HAMILL RJ, HARRISON TS, LARSEN RA, LORTHOLARY O, NGUYEN MH, PAPPAS PG, POWDERLY WG, SINGH N, SOBEL JD, SORRELL TC. Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 291-322.